Equities

Captor Therapeutics SA

Captor Therapeutics SA

Actions
  • Price (EUR)16.25
  • Today's Change-0.25 / -1.52%
  • Shares traded--
  • 1 Year change-30.56%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7691118
Total Receivables, Net139.6812
Total Inventory------
Prepaid expenses0.380.760.91
Other current assets, total------
Total current assets89101131
Property, plant & equipment, net6.951113
Goodwill, net------
Intangibles, net1.470.780.36
Long term investments------
Note receivable - long term------
Other long term assets0.220.230.01
Total assets97113144
LIABILITIES
Accounts payable6.505.653.19
Accrued expenses1.832.161.54
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.533.725.24
Other current liabilities, total161.866.39
Total current liabilities271316
Total long term debt1.253.242.94
Total debt3.786.958.18
Deferred income tax------
Minority interest------
Other liabilities, total0.100.050.03
Total liabilities281719
SHAREHOLDERS EQUITY
Common stock0.470.420.41
Additional paid-in capital------
Retained earnings (accumulated deficit)4476112
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.190.190.19
Total equity6996124
Total liabilities & shareholders' equity97113144
Total common shares outstanding4.654.174.13
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.